1.
Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer. Cermin Dunia Kedokteran. 2022;49(12):693-701. doi:10.55175/cdk.v49i12.329